Acadia Pharmaceuticals (ACAD) Retained Earnings (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted Retained Earnings of -$1.8 billion for Q2 2026, up 1.74% on a QoQ basis from -$1.8 billion in Q1 2026, and up 17.63% year-over-year from -$1.5 billion in Q2 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Retained Earnings (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals has reported Retained Earnings for 17 years, with the latest figure at -$1.8 billion in Q2 2026.
- On a quarterly basis, Retained Earnings rose 17.63% year-over-year to -$1.8 billion in Q2 2026; TTM through Jun 2026 was -$1.8 billion, a 17.63% increase from a year earlier, with the FY2025 full-year figure at -$1.8 billion, up 17.74% from the prior year.
- Retained Earnings was -$1.8 billion for Q2 2026 at Acadia Pharmaceuticals, up from -$1.8 billion in the prior quarter.
- The five-year high for Retained Earnings was -$1.8 billion in Q2 2026, with the low at -$2.5 billion in Q3 2023.
- Average Retained Earnings over 5 years is -$2.2 billion, with a median of -$2.3 billion recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings slipped 10.45% in 2022, then gained 17.74% in 2025.
- Over 5 years, Retained Earnings stood at -$2.4 billion in 2022, then dropped by 2.59% to -$2.4 billion in 2023, then rose by 9.32% to -$2.2 billion in 2024, then increased by 17.74% to -$1.8 billion in 2025, then advanced by 1.94% to -$1.8 billion in 2026.
- The last three Retained Earnings figures came in at -$1.8 billion (Q2 2026), -$1.8 billion (Q1 2026), and -$1.8 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 9.53 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 15.69 Bn |
| 10 | Acadia Pharmaceuticals | 4.38 Bn | 3.42 Bn | 279.64 Mn | -1.78 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.78 Bn |
| Mar 31, 2026 | -1.81 Bn |
| Dec 31, 2025 | -1.81 Bn |
| Sep 30, 2025 | -2.09 Bn |
| Jun 30, 2025 | -2.16 Bn |
| Mar 31, 2025 | -2.19 Bn |
| Dec 31, 2024 | -2.20 Bn |
| Sep 30, 2024 | -2.35 Bn |
| Jun 30, 2024 | -2.38 Bn |
| Mar 31, 2024 | -2.41 Bn |
| Dec 31, 2023 | -2.43 Bn |
| Sep 30, 2023 | -2.48 Bn |
| Jun 30, 2023 | -2.41 Bn |
| Mar 31, 2023 | -2.41 Bn |
| Dec 31, 2022 | -2.37 Bn |
| Sep 30, 2022 | -2.33 Bn |
| Jun 30, 2022 | -2.30 Bn |
| Mar 31, 2022 | -2.27 Bn |
| Dec 31, 2021 | -2.15 Bn |
| Sep 30, 2021 | -2.11 Bn |
API Access
Acadia Pharmaceuticals Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();